SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-140992
Filing Date
2020-12-31
Accepted
2020-12-31 16:30:27
Documents
1
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2039708-1_form5.html 5  
1 OWNERSHIP DOCUMENT tm2039708-1_form5.xml 5 14544
  Complete submission text file 0001104659-20-140992.txt   16199
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Issuer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 750 LEXINGTON AVE NEW YORK NY 10022
Business Address
WEISS MICHAEL S (Reporting) CIK: 0001038977 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-32639 | Film No.: 201429132